middle.news
How Will Resonance Health’s AI-Powered Devices Drive $17M Revenue by FY26?
1:21pm on Monday 13th of October, 2025 AEDT
•
Healthcare
Read Story
How Will Resonance Health’s AI-Powered Devices Drive $17M Revenue by FY26?
1:21pm on Monday 13th of October, 2025 AEDT
Key Points
Projected revenue growth from $4.4M in FY23 to ~$17M in FY26
Target EBITDA margin of approximately 25% with operational cash flow positivity
Expansion of Software-as-Medical Devices (SaMD) portfolio leveraging AI technology
Geographic and therapeutic area diversification including acquisitions
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE